An interventional study of questionnaire via smartphone in Coagulation Disorder, sponsored by Fondation Hôpital Saint-Joseph. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-10-09.
Sponsored by Fondation Hôpital Saint-Joseph · Not applicable, Interventional, and Other
Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up.
The purpose of the study is to evaluate smartphone use to follow the patients'treatment.
Two questionnaire via smartphone with 15 days gap.
515 studies on the registry are indexed under Hemostatic Disorders; 72 are open to participants now.
This study's enrollment of 100 is above the median of 52 across 261 interventional studies indexed under Hemostatic Disorders.
Browse Hemostatic Disorders studies →Fondation Hôpital Saint-Joseph is the lead sponsor of 344 studies on the registry; 49 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
questionnaire via smartphone
smartphone use level
evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment
Time frame: 15 days
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondation Hôpital Saint-Joseph →